Oxycodone for neuropathic pain in adults.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Cochrane Database of Systematic Reviews

• Publication date

  2016-07-28

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/14651858.CD010692.pub3PMID 27465317PMCID PMC6457997
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Oxycodone for cancer-related pain.

  2022cited by this paper
• Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

  2019cited by this paper
• Oxycodone for cancer-related pain.

  2017cited by this paper
• WHO analgesic ladder: a good concept gone astray

  2016cited by this paper
• Opioide bei chronischem Kreuzschmerz

  2015cited by this paper
• Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis.

  2015cited by this paper
• (445) Efficacy and safety of oxycodone DETERx: results of a randomized, double-blind, placebo-controlled phase III study

  2015cited by this paper
• Systematic review of enriched enrolment, randomised withdrawal trial designs in chronic pain: a new framework for design and reporting

  2015cited by this paper
• Individualized Pharmacological Treatment of Neuropathic Pain

  2015cited by this paper
• Physical Functioning and Opioid use in Patients with Neuropathic Pain.

  2015cited by this paper
• The effect of oxcarbazepine in peripheral neuropathic pain depends on pain phenotype: A randomised, double‐blind, placebo‐controlled phenotype‐stratified study

  2014cited by this paper
• Neuropathic pain in the general population: A systematic review of epidemiological studies

  2014cited by this paper
• Topical lidocaine for neuropathic pain in adults.

  2014cited by this paper
• Gabapentin for chronic neuropathic pain and fibromyalgia in adults.

  2014cited by this paper
• Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia.

  2014cited by this paper
• (454) A randomized, double-blind, placebo-controlled, multicenter trial to assess the efficacy and safety of oxycodone/naloxone extended-release tablets (OXN) in opioid-experienced subjects with chronic low back pain

  2014cited by this paper
• The Costs and Consequences of Adequately Managed Chronic Non‐Cancer Pain and Chronic Neuropathic Pain

  2014cited by this paper
• Opioide bei chronischem neuropathischem Schmerz

  2014cited by this paper
• Oxycodone for neuropathic pain and fibromyalgia in adults.

  2014cited by this paper
• Antiepileptic drugs for neuropathic pain and fibromyalgia - an overview of Cochrane reviews.

  2013cited by this paper
• Rationale and design of the Oxycodone Users Registry: a prospective, multicenter registry of patients with nonmalignant pain.

  2013cited by this paper
• Neuropathic pain needs systematic classification

  2013cited by this paper
• Opioids in the UK: what’s the problem?

  2013cited by this paper
• Expect analgesic failure; pursue analgesic success

  2013cited by this paper
• An observational descriptive study of the epidemiology and treatment of neuropathic pain in a UK general population

  2013cited by this paper
• GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes.

  2013cited by this paper
• Topical capsaicin (low concentration) for chronic neuropathic pain in adults

  2013cited by this paper
• Amitriptyline for neuropathic pain and fibromyalgia in adults.

  2013cited by this paper
• Opioids for neuropathic pain.

  2013cited by this paper
• Abuse rates and routes of administration of reformulated extended-release oxycodone: initial findings from a sentinel surveillance sample of individuals assessed for substance abuse treatment.

  2013cited by this paper
• GRADE guidelines: 12. Preparing summary of findings tables-binary outcomes.

  2013cited by this paper
• Drugs for neuropathic pain

  2013cited by this paper
• Duloxetine use in chronic painful conditions – individual patient data responder analysis

  2013cited by this paper
• Pain measures and cut‐offs – ‘no worse than mild pain’ as a simple, universal outcome

  2013cited by this paper
• Influence of trial sample size on treatment effect estimates: meta-epidemiological study

  2013cited by this paper
• The effect of opioid therapy on endocrine function.

  2013cited by this paper
• Does the pharmacology of oxycodone justify its increasing use as an analgesic?

  2013cited by this paper
• Estimate at your peril: Imputation methods for patient withdrawal can bias efficacy outcomes in chronic pain trials using responder analyses

  2012cited by this paper
• The role of the immune system in the generation of neuropathic pain.

  2012cited by this paper
• Deconstructing the neuropathic pain phenotype to reveal neural mechanisms.

  2012cited by this paper
• Topical capsaicin (low concentration) for chronic neuropathic pain in adults.

  2012cited by this paper
• Chronic pain: genes, plasticity, and phenotypes

  2012cited by this paper
• Mean analgesic consumption is inappropriate for testing analgesic efficacy in post-operative pain: analysis and alternative suggestion

  2011cited by this paper
• Gabapentin for chronic neuropathic pain and fibromyalgia in adults.

  2011cited by this paper
• A new definition of neuropathic pain

  2011cited by this paper
• Minimum efficacy criteria for comparisons between treatments using individual patient meta‐analysis of acute pain trials: Examples of etoricoxib, paracetamol, ibuprofen, and ibuprofen/paracetamol combinations after third molar extraction

  2011cited by this paper
• Efficacy and safety of buprenorphine transdermal system (BTDS) for chronic moderate to severe low back pain: a randomized, double-blind study.

  2011cited by this paper
• Chapter 12: Interpreting results and drawing conclusions

  2011cited by this paper
• Efficacy and safety of tapentadol prolonged release for chronic osteoarthritis pain and low back pain

  2010cited by this paper
• Long‐term Safety and Tolerability of Tapentadol Extended Release for the Management of Chronic Low Back Pain or Osteoarthritis Pain

  2010cited by this paper
• How do changes in pain severity levels correspond to changes in health status and function in patients with painful diabetic peripheral neuropathy?

  2010cited by this paper
• A randomized, controlled trial of oxycodone versus placebo in patients with postherpetic neuralgia and painful diabetic neuropathy treated with pregabalin.

  2010cited by this paper
• Chronic low back pain analgesic studies--a methodological minefield.

  2010cited by this paper
• Fibromyalgia: Moderate and substantial pain intensity reduction predicts improvement in other outcomes and substantial quality of life gain

  2010cited by this paper
• Numbers‐needed‐to‐treat analyses – Do timing, dropouts, and outcome matter? Pooled analysis of two randomized, placebo‐controlled chronic low back pain trials

  2010cited by this paper
• Patient-centered perspective on treatment outcomes in chronic pain.

  2010cited by this paper
• “Evidence” in chronic pain – establishing best practice in the reporting of systematic reviews

  2010cited by this paper
• Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study

  2010cited by this paper
• Efficacy and safety of tapentadol extended release for the management of chronic low back pain: results of a prospective, randomized, double-blind, placebo- and active-controlled Phase III study

  2010cited by this paper
• EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision

  2010cited by this paper
• Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice

  2009cited by this paper
• Oxycodone: new ‘old’ drug

  2009cited by this paper
• Book Review: Systematic Reviews in Pain Research: Methodology Refined

  2009cited by this paper
• Combined prolonged-release oxycodone and naloxone improves bowel function in patients receiving opioids for moderate-to-severe non-malignant chronic pain: a randomised controlled trial

  2009cited by this paper
• Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone

  2009cited by this paper
• Pregabalin for acute and chronic pain in adults.

  2009cited by this paper
• Single dose oral oxycodone and oxycodone plus paracetamol (acetaminophen) for acute postoperative pain in adults.

  2009cited by this paper
• Incidence of facial pain in the general population

  2009cited by this paper
• Analgesic effect of oxycodone-acetaminophen tablet in treatment of backleg pain

  2009cited by this paper
• Fixed-ratio combination oxycodone/naloxone compared with oxycodone alone for the relief of opioid-induced constipation in moderate-to-severe noncancer pain.

  2008cited by this paper
• Controlled-Release Oxycodone and Pregabalin in the Treatment of Neuropathic Pain: Results of a Multicenter Italian Study

  2008cited by this paper
• Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations.

  2008cited by this paper
• Analgesic efficacy and safety of oxycodone in combination with naloxone as prolonged release tablets in patients with moderate to severe chronic pain.

  2008cited by this paper
• Prolonged‐release oxycodone enhances the effects of existing gabapentin therapy in painful diabetic neuropathy patients

  2008cited by this paper
• Neuropathic pain

  2008cited by this paper
• Primary care incidence and treatment of four neuropathic pain conditions: A descriptive study, 2002–2005

  2008cited by this paper
• Enriched enrollment: definition and effects of enrichment and dose in trials of pregabalin and gabapentin in neuropathic pain. A systematic review.

  2008cited by this paper
• Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials

  2008cited by this paper
• Fixed-ratio combination oxycodone/naloxone compared with oxycodone alone for the relief of opioid-induced constipation in moderate-to-severe noncancer pain

  2008cited by this paper
• Chapter 8: Assessing risk of bias in included studies

  2008cited by this paper
• Prevalence of chronic pain with neuropathic characteristics in the general population

  2008cited by this paper
• Pharmacologic management of neuropathic pain: Evidence‐based recommendations

  2007cited by this paper
• How different is oxycodone from morphine?

  2007cited by this paper
• Prevalence of self‐reported neuropathic pain and impact on quality of life: a prospective representative survey

  2007cited by this paper
• Oxytrex minimizes physical dependence while providing effective analgesia: a randomized controlled trial in low back pain.

  2006cited by this paper
• The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey.

  2006cited by this paper
• Efficacy and safety of oxymorphone extended release in chronic low back pain: results of a randomized, double-blind, placebo- and active-controlled phase III study.

  2005cited by this paper
• Controlled‐release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy

  2003cited by this paper
• [Controlled-release oxycodone -- a therapeutic option for severe neuropathic pain].

  2003cited by this paper
• Controlled-release oxycodone for pain in diabetic neuropathy

  2003cited by this paper
• Meta-analyses involving cross-over trials: methodological issues.

  2002cited by this paper
• Efficacy and safety of controlled-release versus immediate-release oxycodone: randomized, double-blind evaluation in patients with chronic back pain.

  1999cited by this paper
• Size is everything – large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects

  1998cited by this paper
• Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia.

  1998cited by this paper
• An Evidence-Based Resource for Pain Relief

  1998cited by this paper
• The importance of quality of primary studies in producing unbiased systematic reviews.

  1996cited by this paper
• Assessing the quality of reports of randomized clinical trials: is blinding necessary?

  1996cited by this paper
• Trigeminal neuralgia: The role of self-sustaining discharge in the trigeminal ganglion

  1994cited by this paper
• A review of oxycodone's clinical pharmacokinetics and pharmacodynamics.

  1993cited by this paper
• Epidemiology and clinical features of idiopathic trigeminal neuralgia and glossopharyngeal neuralgia: similarities and differences, Rochester, Minnesota, 1945-1984.

  1991cited by this paper

• Cannabis-based medicines for chronic neuropathic pain in adults.

  2026cites this paper
• Internet-delivered mindfulness-based cognitive therapy (iMBCT) for chronic pain symptom management in adults: A pilot randomized controlled trial.

  2025cites this paper
• Molecular Mechanisms of Chronic Pain and Therapeutic Interventions

  2025cites this paper
• Spinal neuron-glial crosstalk and ion channel dysregulation in diabetic neuropathic pain

  2025cites this paper
• The Effects of Psychological Treatments for Chronic Pain on Reducing Opioid Use in People at Risk for Opioid Misuse: A Randomized Feasibility Trial

  2025cites this paper
• Executive summary of the guideline for prescribing opioid analgesics for chronic non-cancer pain (third edition) by the Japan Society of Pain Clinicians

  2025cites this paper
• Impact of active placebo controls on estimated drug effects in randomised trials: a meta-epidemiological study.

  2025cites this paper
• Long-Term Effects of Spinal Cord Stimulation on Pain in Postherpetic Neuralgia

  2024cites this paper
• An overview of the non‐procedural treatment options for peripheral neuropathic pain

  2024cites this paper
• A Comprehensive Review of Safety, Efficacy, and Indications for the Use of Alpha-Lipoic Acid and Acetyl-L-Carnitine in Neuropathic Pain.

  2024cites this paper
• Neuropathic Pain in Cancer: What Are the Current Guidelines?

  2024cites this paper
• A fájdalmas diabéteszes neuropátia patogenetikai alapon nyugvó és tüneti kezelésének modern szemlélete

  2024cites this paper
• Analysis of the contributing role of drug transport across biological barriers in the development and treatment of chemotherapy-induced peripheral neuropathy

  2024cites this paper
• The Scientific Doctor

  2024cites this paper
• Opioids today: From pharmacology to crisis management and emerging solutions

  2024cites this paper
• Oxycodone: A Current Perspective on Its Pharmacology, Abuse, and Pharmacotherapeutic Developments

  2023cites this paper
• A comprehensive review of the advances in neuromyelitis optica spectrum disorder.

  2023cites this paper
• Interventions for treating pain and disability in adults with complex regional pain syndrome- an overview of systematic reviews.

  2023cites this paper
• Perioperative opioids: a narrative review contextualising new avenues to improve prescribing.

  2023cites this paper
• Therapeutic Approach for Trigeminal Neuralgia: A Systematic Review

  2023cites this paper
• An anchor-tether 'hindered' HCN1 inhibitor is antihyperalgesic in a rat spared nerve injury neuropathic pain model.

  2023cites this paper
• Conventional management and current guidelines for painful diabetic neuropathy.

  2023cites this paper
• Patterns and Trends in Pharmacological Treatment for Outpatients with Postherpetic Neuralgia in Six Major Areas of China, 2015–2019

  2023cites this paper
• Pharmacological Proposal Approach to Managing Chronic Pain Associated with COVID-19

  2023cites this paper
• Novel Drug Targets and Emerging Pharmacotherapies in Neuropathic Pain

  2023cites this paper
• Consensus guidelines on training, diagnosis, treatment and follow-up care of trigeminal nerve injuries.

  2023cites this paper
• Targeting Chemokines and Chemokine GPCRs to Enhance Strong Opioid Efficacy in Neuropathic Pain

  2022cites this paper
• A Systematic Review on Cannabinoids for Neuropathic Pain Administered by Routes Other than Oral or Inhalation

  2022cites this paper
• Update S3-Leitlinie Intestinale Motilitätsstörungen: Definition, Pathophysiologie, Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Motilität (D

  2022influential citation
• Diabetic Peripheral Neuropathy.

  2022cites this paper
• Pharmacotherapy of Painful Diabetic Neuropathy: A Clinical Update

  2022influential citation
• Prevention and Management Strategies for Diabetic Neuropathy

  2022cites this paper
• Pulsed radiofrequency treatment of the dorsal root ganglion in patients with chronic neuropathic pain: A narrative review

  2022cites this paper
• Current and emerging COX inhibitors for treating postoperative pain following oral surgery

  2022cites this paper
• Application of oxycodone in anesthesia induction and overall management of Da Vinci robot-assisted nephrectomy: A randomized controlled trial

  2022cites this paper
• Neuropathic Pain in Neurologic Disorders: A Narrative Review

  2022cites this paper
• The state-of-the-art pharmacotherapeutic options for the treatment of chronic non-cancer pain

  2022cites this paper
• Lumbar spinal stenosis as a model for the multimodal and multiprofessional treatment of mixed non-cancer pain. Survey response from a panel of experts of the Italian National Association of Osteoarticular Specialists (ASON)

  2021cites this paper
• No Zero Sum in Opioids for Chronic Pain: Neurostimulation and the Goal of Opioid Sparing, Not Opioid Eradication

  2021cites this paper
• The Treatment of Painful Diabetic Neuropathy.

  2021cites this paper
• Tapentadol in Cancer Patients with Neuropathic Pain: A Comparison of Methadone, Oxycodone, Fentanyl, and Hydromorphone.

  2021cites this paper
• Efficacy and Safety of Moxibustion for Postherpetic Neuralgia: A Systematic Review and Meta-Analysis

  2021cites this paper
• Screening, diagnosis and management of diabetic sensorimotor polyneuropathy in clinical practice: International expert consensus recommendations.

  2021cites this paper
• Frequency Rhythmic Electrical Modulation System (FREMS) to alleviate painful diabetic peripheral neuropathy: A pilot, randomised controlled trial (The FREMSTOP study)

  2021cites this paper
• Pathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy

  2021cites this paper
• A critical review of the respiratory benefits and harms of orally administered opioids for dyspnea management in COPD

  2021cites this paper
• Oxycodone self-administration activates the mitogen-activated protein kinase/ mitogen- and stress-activated protein kinase (MAPK-MSK) signaling pathway in the rat dorsal striatum

  2021cites this paper
• Non-canonical molecular targets for novel analgesics: Intracellular calcium and HCN channels.

  2021cites this paper
• Efficacy and Safety of 10 kHz Spinal Cord Stimulation for the Treatment of Chronic Pain: A Systematic Review and Narrative Synthesis of Real-World Retrospective Studies

  2021cites this paper
• Flavonoids in the Treatment of Neuropathic Pain

  2021cites this paper
• Diabetic Neuropathy – Research

  2020cites this paper
• Homeopathy Deserves Its Own Scientific Identity

  2020cites this paper
• Comparison of the use of opioids only and pregabalin add-on for the treatment of neuropathic pain in cervical myelopathy patients: a pilot trial

  2020cites this paper
• Opioid Treatments for Chronic Pain

  2020cites this paper
• Guideline “diagnosis and non interventional therapy of neuropathic pain” of the German Society of Neurology (deutsche Gesellschaft für Neurologie)

  2020cites this paper
• Practical Chronic Pain Management: A Case-Based Approach

  2020cites this paper
• Diabetic Peripheral Neuropathy: Diagnosis and Treatment.

  2020cites this paper
• Post‐operative opioid‐related adverse events with intravenous oxycodone compared to morphine: A randomized controlled trial

  2020influential citation
• Oxycodone self-administration activates the mitogen-activated protein kinase/ mitogen- and stress-activated protein kinase (MAPK-MSK) signaling pathway in the rat dorsal striatum

  2020cites this paper
• Bone fractures in patients using tapentadol or oxycodone: an exploratory US claims database study.

  2020cites this paper
• Dilemma of Addiction and Respiratory Depression in the Treatment of Pain: A Prototypical Endomorphin as a New Approach.

  2020cites this paper
• Controlling the “Opioid Epidemic”: A Novel Chemical Entity (NCE) to Reduce or Supplant Opiate Use for Chronic Pain

  2020influential citation
• The Safety of Medications used to Treat Peripheral Neuropathic Pain, Part 2 (Opioids, Cannabinoids and Other Drugs): review of Double-Blind, Placebo-Controlled, Randomized Clinical Trials

  2020cites this paper
• Pharmacotherapy for Small Fiber Neuropathy

  2020cites this paper
• A 55-Year-Old Diabetic Woman with Feet Pain

  2020cites this paper
• Post-Acute Care Management of Patients with Angiostrongyliasis: A Guideline in Caring for Patients Who Suffer Long Term Sequelae of Rat Lungworm Disease

  2020cites this paper
• NYX-2925, A NOVEL, NON-OPIOID, SMALL-MOLECULE MODULATOR OF THE N-METHYL-d-ASPARTATE RECEPTOR (NMDAR), DEMONSTRATES POTENTIAL TO TREAT CHRONIC, SUPRASPINAL CENTRALIZED PAIN CONDITIONS

  2020cites this paper
• Harpagophytum procumbens Extract Ameliorates Allodynia and Modulates Oxidative and Antioxidant Stress Pathways in a Rat Model of Spinal Cord Injury

  2020cites this paper
• Escalated Oxycodone Self-Administration and Punishment: Differential Expression of Opioid Receptors and Immediate Early Genes in the Rat Dorsal Striatum and Prefrontal Cortex

  2020cites this paper
• Treating Pain in Diabetic Neuropathy: Current and Developmental Drugs

  2020cites this paper
• Treatment :: Peripheral and Autonomic Neuropathies

  2019cites this paper
• Factors Associated With New Persistent Opioid Usage After Lung Resection.

  2019cites this paper
• Pregabalin for neuropathic pain in adults.

  2019cites this paper
• Investigation of Key Genes and Pathways in Inhibition of Oxycodone on Vincristine-Induced Microglia Activation by Using Bioinformatics Analysis

  2019cites this paper
• Comparison of the antinociceptive profiles of morphine and oxycodone in two models of inflammatory and osteoarthritic pain in rat.

  2019cites this paper
• The Use of Opioids for Treatment of Pediatric Neuropathic Pain: A Literature Review

  2019cites this paper
• Behandlungsalgorithmus beim neuropathischen Schmerzsyndrom

  2019cites this paper
• Therapy for Small Fiber Neuropathy

  2019cites this paper
• Post-herpetic Neuralgia

  2019cites this paper
• A Comprehensive Algorithm for Management of Neuropathic Pain

  2019cites this paper
• Escalated oxycodone self-administration causes differential striatal mRNA expression of FGFs and IEGs following abstinence-associated incubation of oxycodone craving.

  2019cites this paper
• Schmerzbehandlung bei diabetischer Polyneuropathie

  2019cites this paper
• Pain management and stroke prevention in HHV-3-associated infection

  2019cites this paper
• Effects of Adding Oxycodone to Ropivacaine on Labor Analgesia

  2019cites this paper
• Should Pregabalin Be Used in the Management of Chronic Neuropathic Pain in Adults? A Cochrane Review Summary With Commentary

  2019cites this paper
• Therapeutic Approaches for Peripheral and Central Neuropathic Pain

  2019cites this paper
• Intravenous oxycodone compared to morphine for post-operative opioid-related adverse events in opioid naïve patients: a prospective randomized controlled trial

  2019cites this paper
• S2k-Leitlinie: Diagnose und nicht interventionelle Therapie neuropathischer Schmerzen

  2019cites this paper
• Opioids for Neuropathic Pain #363

  2018cites this paper
• Considerations in 2017–2018 for the Use of Opioids in Non-terminal Pain

  2018cites this paper
• Are Opioids Effective in Relieving Neuropathic Pain?

  2018cites this paper
• Diabetic Neuropathic Pain Syndromes

  2018cites this paper
• Best Practices Education, Part II: Evidence for and Against Opioid Therapy

  2018cites this paper
• Antipsychotics for the treatment of neuropathic pain in adults

  2018cites this paper
• Cannabis-based medicines for chronic neuropathic pain in adults.

  2018cites this paper
• How does oxycodone compare with placebo in adults with neuropathic pain?

  2018cites this paper
• Why mu‐opioid agonists have less analgesic efficacy in neuropathic pain?

  2018cites this paper
• PharmGKB summary: oxycodone pathway, pharmacokinetics

  2018cites this paper
• Characteristics of fibromyalgia patients prescribed opioid medications: data from the Cleveland Clinic Fibromyalgia Registry

  2018cites this paper
• Oxycodone ameliorates the inflammatory response induced by lipopolysaccharide in primary microglia

  2018cites this paper